Therapy for idiopathic interstitial pneumonias: Steroids - and what else?;Therapie der idiopathischen interstitiellen pneumonien: Steroide - und was noch?

Internist

Volumn 47, Issue 12, 2006, Pages 1258-1262

  Prasse, A ^a   Muller Quernheim J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Collagenosis; Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; Lung parenchyma; Lungs

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE;

BONE MARROW SUPPRESSION; DISEASE CLASSIFICATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LUNG TRANSPLANTATION; MORTALITY; REVIEW;

ADRENAL CORTEX HORMONES; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; PREDNISOLONE; PROGNOSIS; PULMONARY FIBROSIS;

EID: 33845906836     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-006-1734-4     Document Type: Review

References (18)

1. Alalawi R, Whelan T, Bajwa RS et al. (2005) Lung transplantation and interstitial lung disease. Curr Opin Pulm Med 11: 461-466
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) (2000) Am J Respir Crit Care Med 161: 646-664
3. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) Am J Respir Crit Care Med 165: 277-304
4. Costabel U, Guzman J (2003) Lungenfibrose: Klassifikation, Diagnose, Therapie. Internist 44 [Suppl 1]: S35-S43
5. Demedts M, Behr J, Buhl R et al.; IFIGENIA Study Group (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353: 2229-2242
6. Flaherty KR, Martinez FJ, Travis W et al. (2001) Nonspecific interstitial pneumonia (NSIP). Semin Respir Crit Care Med 22: 423-434
7. Kim DS, Collard HR, King TE Jr (2006) Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 3: 285-292
8. Lamblin C, Bergoin C, Saelens T et al. (2001) Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 32: 69s-80s
9. Majeski EI, Paintlia MK, Lopez AD et al. (2003) Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol 163: 1467-1479
10. Martinez FJ, Safrin S, Weycker D et al.; IPF Study Group (2005) The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142: 963-967
11. Raghu G, Brown KK, Bradford WZ et al.; Idiopathic Pulmonary Fibrosis Study Group (2004) A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350: 125-133
12. Ryu JH, Colby TV, Hartman TE et al. (2001) Smoking-related interstitial lung diseases: a concise review. Eur Respir J 17: 122-132
13. Schlesinger C, Koss MN (2005) The organizing pneumonias: an update and review. Curr Opin Pulm Med 11: 422-430
14. Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151
15. Tashkin DP, Elashoff R, Clements PJ et al.; Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354: 2655-2666
16. Vourlekis JS, Brown KK, Cool CD et al. (2000) Acute interstitial pneumonitis: case series and review of the literature. Medicine 79: 369-378
17. Walter N, Collard HR, King TE Jr (2006) Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3: 330-338
18. Ziegenhagen MW, Müller-Quernheim J (2004) Idiopathische pulmonale Fibrose (IPF): Diagnose, Differentialdiagnose und aktuelle Therapieoptionen. Dtsch Med Wochenschr 129: 494-498